-
Mashup Score: 3Circulating tumor cell count-driven vs clinician-driven 1L therapy in HR+, HER2- breast cancer - 3 year(s) ago
Jean-Yves Pierga, MD, PhD, Institut Curie, Paris, France, outlines the results of a Phase III trial comparing the efficacy of…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Key takeaways from the St. Gallen Consensus Panel - 3 year(s) ago
Michael Gnant, MD, Medical University Vienna, Vienna, Austria, talks on highlights from the St. Gallen Consensus Session including the fact…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Key takeaways from the St. Gallen Consensus Panel w/ @MichaelGnant of @MedUni_Wien Watch here 👉 https://t.co/Ersa1tSZlR👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #MedOnc #ClinOnc #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 0Upcoming research into brain metastases in breast cancer - 3 year(s) ago
Nancy Lin, MD, Dana-Farber Cancer Institute, Boston, MA, discusses the greatest areas of research into brain metastases in brain cancer…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Upcoming research into brain metastases in breast cancer w/ @nlinmd of @DanaFarber Watch here 👉https://t.co/CmEma1CViA👈 @VJOncology @OncoAlert #BreastCancer #BCsm #SGBCC21 #BCC21 #OncoAlert #MedOnc #ClinOnc #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 1
A five-part VJ Session featuring GU oncology experts Neal Shore, Bertrand Tombal, Rana McKay & Robert Jones who discuss their highlights from the 2021 ASCO Genitourinary Cancers Symposium. The expert panel explore the data from the practice-changing Phase III SPARTAN, PROSPER & ARAMIS studies in nmCRPC and debate the potential of theranostics, PARP inhibitors and GnRH receptor antagonist. They…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Don't forget to also check out our Breast Cancer Session on key updates from #SGBCC21 Catch up here 👉https://t.co/b5BCCOCSlv👈 @VJOncology @OncoAlert #BreastCancer #BCsm #VJSessions #OncoAlert https://t.co/w1SvNI5kW9
-
-
Mashup Score: 2Will genomic profiling replace clinical and pathological risk factors in ER+ breast cancer? - 3 year(s) ago
Martine Piccart, MD, PhD, Université Libre de Bruxelles, Brussels, Belgium, discusses whether genomic profiling will ever place traditional clinical and…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Will genomic profiling replace clinical and pathological risk factors in ER+ #BreastCancer? w/ Martine Piccart of @ULBruxelles 👉 https://t.co/CqLzGaWuNA👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BCsm #OncoAlert #ClinOnc #MedOnc #Oncology #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 0Diagnostic value of methylation signatures in breast cancer - 3 year(s) ago
Maria Panagopoulou, PhD, Democritus University of Thrace, Alexandroupolis, Greece, discusses the diagnostic value of methylation signatures in patients with breast…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Diagnostic value of methylation signatures in breast cancer w/ Maria Panagopoulou of Democritus University of Thrace 👉 https://t.co/sz2jRzNsE7👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #ClinOnc #MedOnc #Oncology #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 1Breast surgery de-escalation: can we omit surgery altogether? - 3 year(s) ago
Marios Tasoulis, MD, PhD, FEBS, FRCS, The Royal Marsden NHS Foundation Trust, London, UK, talks on the surgical advancements he…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Breast surgery de-escalation: can we omit surgery altogether? w/ @marios_tasoulis of @royalmarsdenNHS 👉 https://t.co/Mzix7Lb4BI👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BCsm #OncoAlert #ClinOnc #MedOnc #Oncology #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 0Predicting pathological complete response in breast cancer - 3 year(s) ago
Tanja Gagliardi, MD, The Royal Marsden NHS Foundation Trust, London, UK, discusses the need for development of modalities that can…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Predicting pathological complete response in #BreastCancer w/ Tanja Gagliardi of @royalmarsdenNHS 👉 https://t.co/IOuc8BLJtO👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BCsm #OncoAlert #ClinOnc #MedOnc #Oncology #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 0Cell-free DNA analysis for breast cancer - 3 year(s) ago
Maria Panagopoulou, PhD, Democritus University of Thrace, Alexandroupolis, Greece, talks on the identification and validation of clinically valuable predictive or…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Cell-free DNA analysis for breast cancer w/ Maria Panagopoulou of Democritus University of Thrace 👉 https://t.co/xhJjKUygnO👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #ClinOnc #MedOnc #Oncology #NCRM21 #ResearchSavesLives
-
-
Mashup Score: 2Highlights from the St. Gallen Consensus Panel - 3 year(s) ago
Giuseppe Curigliano, MD, PhD, University of Milan, Milan, Italy, discusses highlights from the virtual 17th St. Gallen International Breast Cancer…
Source: VJOncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
VIDEO: Highlights from the St. Gallen Consensus Panel w/ @curijoey of @LaStatale 👉 https://t.co/38LOmxto4S👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BreastCancer #BCsm #OncoAlert #ClinOnc #MedOnc #Oncology #NCRM21 #ResearchSavesLives
-
VIDEO: Circulating tumor cell count-driven vs clinician-driven 1L therapy in HR+, HER2- #BreastCancer w/ Jean-Yves Pierga of @institut_curie Watch here 👉 https://t.co/QGbGY4nC5n👈 @VJOncology @OncoAlert #SGBCC21 #BCC21 #BCsm #OncoAlert #MedOnc #NCRM21 #ResearchSavesLives